Inventor
BURNIER JOHN
US22 patents
⚠️ This page may combine multiple inventors who share the name “BURNIER JOHN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SARCODE BIOSCIENCE INC
9 patentsUS9353088B2May 31, 2016
Crystalline pharmaceutical and methods of preparation and use thereof
SARCODE BIOSCIENCE INC36 citations97
US8927574B2Jan 6, 2015
Crystalline pharmaceutical and methods of preparation and use thereof
SARCODE BIOSCIENCE INC48 citations97
US9447077B2Sep 20, 2016
Crystalline pharmaceutical and methods of preparation and use thereof
SARCODE BIOSCIENCE INC40 citations96
US8367701B2Feb 5, 2013
Crystalline pharmaceutical and methods of preparation and use thereof
SARCODE BIOSCIENCE INC63 citations96
US9890141B2Feb 13, 2018
Crystalline pharmaceutical and methods of preparation and use thereof
SARCODE BIOSCIENCE INC27 citations94
US9045457B2Jun 2, 2015
Compositions and methods for treatment
SARCODE BIOSCIENCE INC9 citations92
US8378105B2Feb 19, 2013
Crystalline pharmaceutical and methods of preparation and use thereof
SARCODE BIOSCIENCE INC8 citations84
US8871935B2Oct 28, 2014
Crystalline pharmaceutical and methods of preparation and use thereof
SARCODE BIOSCIENCE INC4 citations83
US10188641B2Jan 29, 2019
Compositions and methods for treatment
SARCODE BIOSCIENCE INC0 citations52
GENENTECH INC
5 patentsUS5665704ASep 9, 1997
Receptor specific atrial natriuretic peptides
GENENTECH INC56 citations92
US5629173AMay 13, 1997
Methods of use of serine protease variants having peptide ligase activity
GENENTECH INC34 citations92
US5403737AApr 4, 1995
Serine protease variants having peptide ligase activity
GENENTECH INC51 citations92
US5736512AApr 7, 1998
Serine protease variants having peptide ligase activity
GENENTECH INC12 citations72
US5763256AJun 9, 1998
Serine protease variants having peptide ligase activity
GENENTECH INC5 citations63